Acorah Software Products - Accounts Production 19.4.351 false true 31 December 2024 1 January 2024 false 1 January 2025 31 December 2025 31 December 2025 13662161 Ms Melissa Sookia Ms M L Sookia false iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 13662161 2024-12-31 13662161 2025-12-31 13662161 2025-01-01 2025-12-31 13662161 frs-core:CurrentFinancialInstruments 2025-12-31 13662161 frs-core:Non-currentFinancialInstruments 2025-12-31 13662161 frs-core:BetweenOneFiveYears 2025-12-31 13662161 frs-core:ComputerEquipment 2025-12-31 13662161 frs-core:ComputerEquipment 2025-01-01 2025-12-31 13662161 frs-core:ComputerEquipment 2024-12-31 13662161 frs-core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2025-12-31 13662161 frs-core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2025-01-01 2025-12-31 13662161 frs-core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-12-31 13662161 frs-core:FurnitureFittings 2025-12-31 13662161 frs-core:FurnitureFittings 2025-01-01 2025-12-31 13662161 frs-core:FurnitureFittings 2024-12-31 13662161 frs-core:LandBuildings frs-core:LeasedAssetsHeldAsLessee 2025-12-31 13662161 frs-core:LandBuildings frs-core:LeasedAssetsHeldAsLessee 2025-01-01 2025-12-31 13662161 frs-core:LandBuildings frs-core:LeasedAssetsHeldAsLessee 2024-12-31 13662161 frs-core:PlantMachinery 2025-12-31 13662161 frs-core:PlantMachinery 2025-01-01 2025-12-31 13662161 frs-core:PlantMachinery 2024-12-31 13662161 frs-core:SharePremium 2025-12-31 13662161 frs-core:ShareCapital 2025-12-31 13662161 frs-core:RetainedEarningsAccumulatedLosses 2025-12-31 13662161 frs-bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 13662161 frs-bus:FilletedAccounts 2025-01-01 2025-12-31 13662161 frs-bus:SmallEntities 2025-01-01 2025-12-31 13662161 frs-bus:AuditExempt-NoAccountantsReport 2025-01-01 2025-12-31 13662161 frs-bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 13662161 1 2025-01-01 2025-12-31 13662161 frs-bus:Director1 2025-01-01 2025-12-31 13662161 frs-bus:Director1 2024-12-31 13662161 frs-bus:Director1 2025-12-31 13662161 frs-countries:EnglandWales 2025-01-01 2025-12-31 13662161 2023-12-31 13662161 2024-12-31 13662161 2024-01-01 2024-12-31 13662161 frs-core:CurrentFinancialInstruments 2024-12-31 13662161 frs-core:Non-currentFinancialInstruments 2024-12-31 13662161 frs-core:BetweenOneFiveYears 2024-12-31 13662161 frs-core:SharePremium 2024-12-31 13662161 frs-core:ShareCapital 2024-12-31 13662161 frs-core:RetainedEarningsAccumulatedLosses 2024-12-31 13662161 frs-core:CurrentFinancialInstruments 3 2024-12-31
Registered number: 13662161
Livve Ltd
Financial Statements
For The Year Ended 31 December 2025
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—6
Page 1
Balance Sheet
Registered number: 13662161
2025 2024
as restated
Notes £ £ £ £
FIXED ASSETS
Intangible Assets 4 26,596 39,895
Tangible Assets 5 16,875 2,386
43,471 42,281
CURRENT ASSETS
Stocks 6 2,500 -
Debtors 7 38,248 24,611
Cash at bank and in hand 11,837 4,411
52,585 29,022
Creditors: Amounts Falling Due Within One Year 8 (80,829 ) (20,879 )
NET CURRENT ASSETS (LIABILITIES) (28,244 ) 8,143
TOTAL ASSETS LESS CURRENT LIABILITIES 15,227 50,424
Creditors: Amounts Falling Due After More Than One Year 9 - (5,337 )
NET ASSETS 15,227 45,087
CAPITAL AND RESERVES
Called up share capital 10 21,999 21,999
Share premium account 244,962 244,962
Profit and Loss Account (251,734 ) (221,874 )
SHAREHOLDERS' FUNDS 15,227 45,087
Page 1
Page 2
For the year ending 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Ms Melissa Sookia
Director
25th September 2026
The notes on pages 3 to 6 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Livve Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 13662161 . The registered office is 7 Limewood Way, Seacroft, Leeds, LS14 1AB.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
Sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods has transferred to the buyer. This is usually at the point that the customer has signed for the delivery of the goods.
Rendering of services
Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
2.3. Research and Development
In the research phase of an internal project it is not possible to demonstrate that the project will generate future economic benefits and hence all expenditure on research is recognised as an expense when it is incurred. Intangible assets are recognised from the development phase of a project if and only if certain specific criteria are met in order to demonstrate the asset will generate probable future economic benefits and that its cost can be reliably measured. 
If it is not possible to distinguish between the research phase and the development phase of an internal project the expenditure is treated as if it were all incurred in the research phase only.
Capitalised development costs are amortised on a straight line basis over five years from the date the platform was brought into use. The comparative figures have been restated to apply this policy from 2023 (note 13).
2.4. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Leasehold Straight line over the term of the lease
Plant & Machinery 20% Reducing Balance
Fixtures & Fittings 20% Reducing Balance
Computer Equipment 20% Reducing Balance
2.5. Leasing and Hire Purchase Contracts
Rentals payable under operating leases, including any initial rental and the benefit of any rent-free period, are charged to the profit and loss account on a straight line basis over the lease term.
2.6. Stocks and Work in Progress
Stocks and work in progress are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow-moving stocks. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads. Work-in-progress is reflected in the accounts on a contract by contract basis by recording turnover and related costs as contract activity progresses.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 2 (2024: 3)
2 3
Page 3
Page 4
4. Intangible Assets
Development Costs
£
Cost
As at 1 January 2025 66,491
As at 31 December 2025 66,491
Amortisation
As at 1 January 2025 26,596
Provided during the period 13,299
As at 31 December 2025 39,895
Net Book Value
As at 31 December 2025 26,596
As at 1 January 2025 39,895
5. Tangible Assets
Land & Property
Leasehold Plant & Machinery Fixtures & Fittings Computer Equipment Total
£ £ £ £ £
Cost
As at 1 January 2025 - 1,282 1,085 1,256 3,623
Additions 7,786 - 7,694 1,416 16,896
As at 31 December 2025 7,786 1,282 8,779 2,672 20,519
Depreciation
As at 1 January 2025 - 256 369 612 1,237
Provided during the period 108 205 1,682 412 2,407
As at 31 December 2025 108 461 2,051 1,024 3,644
Net Book Value
As at 31 December 2025 7,678 821 6,728 1,648 16,875
As at 1 January 2025 - 1,026 716 644 2,386
6. Stocks
2025 2024
as restated
£ £
Stock 2,500 -
Page 4
Page 5
7. Debtors
2025 2024
as restated
£ £
Due within one year
Trade debtors 19,760 7,492
Prepayments and accrued income 6,142 -
Other debtors 839 -
Corporation tax recoverable assets 400 -
VAT 5,362 16,541
Other taxes and social security - 578
32,503 24,611
Due after more than one year
Other debtors 5,745 -
38,248 24,611
Other debtors due after more than one year comprise a rent deposit of £5,745 held by the landlord of the company's clinic premises.
8. Creditors: Amounts Falling Due Within One Year
2025 2024
as restated
£ £
Trade creditors 31,618 8,219
Other loans 1,438 -
Other taxes and social security 287 -
Other creditors 41,623 -
Other creditors (3) - 11,160
Accruals and deferred income 2,985 1,500
Director's loan account 2,878 -
80,829 20,879
Other loans comprise a merchant cash advance from PayPal Working Capital of £6,311 (2024, restated: £11,160) and a Capital on Tap facility of £1,438 (2024: £nil). The loan from a shareholder of £35,000 is interest free and repayable within 30 days of written demand.
9. Creditors: Amounts Falling Due After More Than One Year
2025 2024
as restated
£ £
Other creditors - 5,337
10. Share Capital
2025 2024
as restated
£ £
Allotted, Called up and fully paid 21,999 21,999
Allotted, called up and fully paid: 21,999 (2024: 21,999) ordinary shares of £1 each. There were no changes in share capital during the year.
Page 5
Page 6
11. Other Commitments
The total of future minimum lease payments under non-cancellable operating leases are as following:
2025 2024
as restated
£ £
Later than one year and not later than five years 44,656 -
44,656 -
At 31 December 2025 the company had total future minimum payments under non-cancellable operating leases of £44,656 (2024: £nil), in respect of its clinic premises to the first break date and a motor vehicle.
12. Directors Advances, Credits and Guarantees
Included within Debtors are the following loans to directors:
As at 1 January 2025 Amounts advanced Amounts repaid Amounts written off As at 31 December 2025
£ £ £ £ £
Ms Melissa Sookia - 27,980 30,858 - (2,878 )
During the year the company made advances to Ms M L Sookia, a director, which were unsecured, interest free and repayable on demand. The balance at 1 January 2025 was £nil; advances of £27,980 were made and £30,858 was repaid, including £12,570 of net salary credited to the account, so that at 31 December 2025 the company owed the director £2,878. The maximum amount outstanding from the director during the year was £13,137.
13. Related Party Transactions
Invigorate Face Ltd (formerly Invigorate-IV Ltd) is a company of which Ms M L Sookia is the sole director and shareholder. During the year Invigorate Face Ltd charged the company £31,920 (2024: £14,000) for the specialist clinical services of Ms Sookia, which was settled in full during the year. The company also repaid in full a loan of £5,337 from Invigorate Face Ltd and received contributions of £3,084 from it towards shared premises costs; £63 was owed to the company by Invigorate Face Ltd at the year end.
14. Controlling Party
The company is controlled by Ms M L Sookia, who holds 67.7% of the issued share capital.
Page 6